Smooth Muscle Cell-Proteoglycan-Lipoprotein Interactions as Drivers of Atherosclerosis.

Allahverdian, Sima; Ortega, Carleena; Francis, Gordon A

Allahverdian, Sima; Ortega, Carleena; Francis, Gordon A.

Afiliação

Allahverdian S; Department of Medicine, Centre for Heart Lung Innovation, Providence Healthcare Research Institute, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Ortega C; Department of Medicine, Centre for Heart Lung Innovation, Providence Healthcare Research Institute, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Francis GA; Department of Medicine, Centre for Heart Lung Innovation, Providence Healthcare Research Institute, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada. gordon.francis@hli.ubc.ca.

Handb Exp Pharmacol ; 270: 335-358, 2022.

Article em En | MEDLINE | ID: mdl-33340050

Assuntos

Aterosclerose; Proteoglicanas; Animais; Aterosclerose/etiologia; Lipoproteínas; Camundongos; Músculo Liso Vascular; Miócitos de Músculo Liso

Palavras-chave

Atherosclerosis; Biglycan; Diffuse intimal thickening; Extracellular matrix; Lipoprotein retention; Proteoglycans; Response to retention; Smooth muscle; Smooth muscle cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteoglicanas / Aterosclerose Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google